Treatment Registry
TR-0481 ActiveRecorded September 2026

Unspecified GLP-1

Sold by Cabana · every unspecified glp-1 record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$249

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Category starting price · recorded initial monthly payment$249

Added from the figures recorded below.

Price

TermPer monthCharged today
Category starting price

“Weight loss support Tailored to you Starting At $249/month”

Per month$249Charged today$249
Price sources
Visit Cabana

We earn nothing from this link. It opens Cabana's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyF&F Pharmacies Inc dba Jungle Jim's Pharmacy
PrescriberBoth
CancellationSubscription auto-renews monthly. Cancel anytime in your Patient Portal or by contacting support.

Not yet checked: states, membership and consult fee.

Recorded from trycabana.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Sells semaglutide injection, semaglutide tablet, and tirzepatide injection (each has its own product page, and each carries an 'Includes Membership' badge meaning the membership is bundled into the price, not billed separately), but only one 'Starting At $249/month' category-wide price is published; it is not tied to a specific product, so it was recorded as unspecified GLP-1. Per-drug pricing pages (/explore/semaglutide, /explore/tirzepatide) linked from the FAQ both 404. Pharmacy licensing text names the 10 states NOT served, out of 50 — recording the inverse as a 'served' list would misstate coverage, per this register's own guidance, so states were left not-found with the exclusion sentence quoted verbatim.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0481
Medication category
unspecified GLP-1
Readings
1

Related records

Unspecified GLP-1 at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 73 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Cabana — unspecified GLP-1 (TR-0481). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0481

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.